SEC Form 4 · Updated Daily
XERS
— XERIS BIOPHARMA HOLDINGS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Edick Paul R | Director | 3,788,064 | 2024-01-31 | A |
| Shannon John Patrick Jr | Director · Officer | 2,898,933 | 2026-08-01 | F |
| McCulloch Kevin | Officer | 1,599,208 | 2026-10-01 | S |
| Pieper Steven | Officer | 1,351,053 | 2026-10-01 | S |
| Hecht Beth | Officer | 1,111,130 | 2026-10-01 | S |
| PRESTRELSKI STEVEN | Officer | 719,780 | 2023-01-31 | A |
| JOHNSON JOHN | Director | 707,276 | 2026-06-04 | A |
| Nguyen Anh Tu | Officer | 395,023 | 2026-02-24 | F |
| JOHNSON KENNETH ERLAND | Officer | 346,288 | 2025-01-31 | F |
| SHERMAN JEFFREY W | Director | 261,420 | 2025-08-28 | M |
| Kong Garheng | Director | 238,337 | 2026-06-04 | A |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | 150,693 | 2026-06-04 | A |
| PERSKY MARLA | Director | 150,693 | 2026-06-04 | A |
| Fairley Ricki Louise | Director | 135,000 | 2024-06-05 | A |
| HALKUFF DAWN | Director | 119,193 | 2026-06-04 | A |
| Brady James Aloysius | Director | 113,359 | 2026-06-04 | A |
| KREHER NERISSA | Director | 33,582 | 2026-07-01 | A |
| Schmid John P. | Director | 25,200 | 2024-08-12 | P |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-10-01 | Hecht Beth | Open-market sale | 16,666 | $9.41 | 1,111,130 |
| 2026-10-01 | McCulloch Kevin | Open-market sale | 15,000 | $9.41 | 1,599,208 |
| 2026-10-01 | Pieper Steven | Open-market sale | 5,000 | $9.41 | 1,351,053 |
| 2026-09-28 | McCulloch Kevin | Open-market sale | 25,000 | $10.00 | 1,614,208 |
| 2026-09-01 | Pieper Steven | Open-market sale | 5,000 | $8.50 | 1,356,053 |
| 2026-09-01 | Hecht Beth | Open-market sale | 16,666 | $8.49 | 1,127,796 |
| 2026-09-01 | McCulloch Kevin | Open-market sale | 15,000 | $8.49 | 1,639,208 |
| 2026-08-12 | Pieper Steven | Open-market sale | 5,000 | $8.50 | 1,361,053 |
| 2026-08-03 | Hecht Beth | Open-market sale | 16,666 | $8.01 | 1,144,462 |
| 2026-08-03 | McCulloch Kevin | Open-market sale | 15,000 | $8.02 | 1,676,126 |
| 2026-08-01 | McCulloch Kevin | Tax withholding | 21,918 | $8.08 | 1,654,208 |
| 2026-08-01 | Shannon John Patrick Jr | Tax withholding | 36,645 | $8.08 | 2,898,933 |
| 2026-07-07 | Pieper Steven | Open-market sale | 27,600 | $8.52 | 1,366,053 |
| 2026-07-06 | Pieper Steven | Open-market sale | 17,400 | $8.50 | 1,393,653 |
| 2026-07-01 | Hecht Beth | Open-market sale | 16,666 | $8.03 | 1,161,128 |
| 2026-07-01 | McCulloch Kevin | Open-market sale | 90,000 | $8.03 | 1,691,126 |
| 2026-07-01 | KREHER NERISSA | Grant / award (derivative) | 37,910 | $8.00 | 37,910 |
| 2026-07-01 | KREHER NERISSA | Grant / award | 33,582 | $0.00 | 33,582 |
| 2026-06-04 | Brady James Aloysius | Grant / award (derivative) | 32,996 | $6.15 | 32,996 |
| 2026-06-04 | Brady James Aloysius | Grant / award | 24,193 | $0.00 | 113,359 |
| 2026-06-04 | JOHNSON JOHN | Grant / award (derivative) | 32,996 | $6.15 | 32,996 |
| 2026-06-04 | JOHNSON JOHN | Grant / award | 24,193 | $0.00 | 707,276 |
| 2026-06-04 | JOHNSON JOHN | Open-market sale | 15,000 | $6.09 | 683,083 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Grant / award (derivative) | 32,996 | $6.15 | 32,996 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Grant / award | 24,193 | $0.00 | 150,693 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Open-market sale | 16,000 | $6.09 | 126,500 |
| 2026-06-04 | HALKUFF DAWN | Grant / award (derivative) | 32,996 | $6.15 | 32,996 |
| 2026-06-04 | HALKUFF DAWN | Grant / award | 24,193 | $0.00 | 119,193 |
| 2026-06-04 | HALKUFF DAWN | Open-market sale | 20,000 | $6.09 | 95,000 |
| 2026-06-04 | PERSKY MARLA | Grant / award (derivative) | 32,996 | $6.15 | 32,996 |
| 2026-06-04 | PERSKY MARLA | Grant / award | 24,193 | $0.00 | 150,693 |
| 2026-06-04 | Kong Garheng | Grant / award (derivative) | 32,996 | $6.15 | 32,996 |
| 2026-06-04 | Kong Garheng | Grant / award | 24,193 | $0.00 | 238,337 |
| 2026-06-03 | PERSKY MARLA | Open-market sale | 15,500 | $5.90 | 126,500 |
| 2026-06-01 | Hecht Beth | Open-market sale | 16,667 | $6.06 | 1,176,506 |
| 2026-05-01 | Hecht Beth | Open-market sale | 16,667 | $6.23 | 1,193,173 |
| 2026-04-01 | Hecht Beth | Open-market sale | 16,667 | $5.99 | 1,209,840 |
| 2026-03-30 | Brady James Aloysius | Open-market sale | 10,834 | $5.54 | 89,166 |
| 2026-03-12 | McCulloch Kevin | Option exercise (derivative) | 4 | $3.94 | 79,996 |
| 2026-03-12 | McCulloch Kevin | Option exercise (derivative) | 48,894 | $4.09 | 43,773 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.